Showing results (1351-1360 of 1,430) with videos related to
Sort By:
Pageof 143
Frontiers in Immunology|May 15, 2018
Immunization Elicits Antigen-Specific Antibody Sequestration in Dorsal Root Ganglia Sensory NeuronsManojkumar Gunasekaran, Prodyot K Chatterjee, Andrew Shih, et al.Nature|March 30, 2001
Essential role of the mitochondrial apoptosis-inducing factor in programmed cell deathN Joza, S A Susin, E Daugas, et al.The Journal of Clinical Investigation|November 13, 2012
Cancer susceptibility and embryonic lethality in Mob1a/1b double-mutant miceMiki Nishio, Koichi Hamada, Kohichi Kawahara, et al.Proceedings of the National Academy of Sciences of the United States of America|March 3, 2015
Mutant IDH is sufficient to initiate enchondromatosis in miceMakoto Hirata, Masato Sasaki, Rob A Cairns, et al.Journal of Medicinal Chemistry|July 9, 2013
The discovery of PLK4 inhibitors: (E)-3-((1H-Indazol-6-yl)methylene)indolin-2-ones as novel antiproliferative agentsRadoslaw Laufer, Bryan Forrest, Sze-Wan Li, et al.Blood|March 28, 2015
B7-H3 expression in donor T cells and host cells negatively regulates acute graft-versus-host disease lethalityRachelle G Veenstra, Ryan Flynn, Katharina Kreymborg, et al.Proceedings of the National Academy of Sciences of the United States of America|September 22, 2020
Endoplasmic reticulum chaperones stabilize ligand-receptive MR1 molecules for efficient presentation of metabolite antigensHamish E G McWilliam, Jeffrey Y W Mak, Wael Awad, et al.Nature Communications|January 14, 2017
K48-linked KLF4 ubiquitination by E3 ligase Mule controls T-cell proliferation and cell cycle progressionZhenyue Hao, Yi Sheng, Gordon S Duncan, et al.Scientific Reports|February 26, 2021
Dj1 deficiency protects against atherosclerosis with anti-inflammatory response in macrophagesTharini Sivasubramaniyam, Jiaqi Yang, Henry S Cheng, et al.Journal for Immunotherapy of Cancer|June 15, 2022
Increase in serum choline levels predicts for improved progression-free survival (PFS) in patients with advanced cancers receiving pembrolizumabGeoffrey Alan Watson, Enrique Sanz-Garcia, Wen-Jiang Zhang, et al.Pageof 143